Irish microneedle start-up recognised at IDEATE Ireland
UCD spin-out MicroJect has been recognised for a polymer microneedle platform designed to support more consistent intradermal delivery.
MicroJect, a University College Dublin MedTech spin-out, has received the first runner-up award at the 2026 IDEATE Ireland competition.
The company is developing a polymer microneedle platform intended to deliver substances into the dermis without conventional metal needles. Its multi-outlet, multi-depth design aims to support accurate and consistent delivery while reducing discomfort, training requirements and reliance on sharp metal waste.
The recognition highlights continued Irish innovation at the intersection of medical-device design, advanced polymers and patient-centred healthcare. For early-stage MedTech companies, progress from concept to a manufacturable product will depend not only on the delivery mechanism, but also on material selection, repeatability, sterility, packaging, quality systems and regulatory evidence.
MicroJect’s development is also a useful reminder that apparently simple disposable devices can involve complex manufacturing and validation requirements. Addressing these considerations early can reduce technical risk and strengthen the pathway towards clinical and commercial use.
Original article
UCD spin-out scoops IDEATE Ireland startup competition award
Engineers Ireland
Published 22 July 2026